Mabel Catalán
Impact in
-
- Cardiac Fibrosis and Remodeling
- Toxicology top 10%
- Bioactive Compounds and Antitumor Agents
Papers in
-
- Cardiac Fibrosis and Remodeling 13
-
- Bioactive Compounds and Antitumor Agents 4
- Co-authors
- Raúl Vivar (17 shared papers)Guillermo Dı́az-Araya (12 shared papers)Ivonne Olmedo (13 shared papers)Jorge Ferreira (6 shared papers)Sergio Lavandero (7 shared papers)Claudio D Humeres (7 shared papers)Pedro Ayala (6 shared papers)José Antonio Jara (9 shared papers)
- Journals
- Toxicology and Applied Pharmacology (4 papers)Cellular Signalling (4 papers)Toxicology in Vitro (3 papers)Advances in experimental medicine and biology (2 papers)RSC Medicinal Chemistry (1 paper)
- Partner nations
- ChileUnited StatesSpain
In The Last Decade
Mabel Catalán
28 papers receiving 419 citations
Peers
Comparison fields: 5 of 69
- Cardiology and Cardiovascular Medicine 108
- Toxicology 17
- Biochemistry 21
- Cancer Research 33
- Molecular Biology 125
Countries citing papers authored by Mabel Catalán
This map shows the geographic impact of Mabel Catalán's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mabel Catalán with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mabel Catalán more than expected).
Fields of papers citing papers by Mabel Catalán
This network shows the impact of papers produced by Mabel Catalán. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mabel Catalán. The network helps show where Mabel Catalán may publish in the future.
Co-authors
The 25 scholars most cited alongside Mabel Catalán, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 48 | |
| 2 | 2011 | 36 | |
| 3 | 2020 | 31 | |
| 4 | 2020 | 31 | |
| 5 | 2016 | 27 | |
| 6 | 2020 | 25 | |
| 7 | 2012 | 22 | |
| 8 | 2010 | 20 | |
| 9 | 2012 | 19 | |
| 10 | 2014 | 18 | |
| 11 | 2013 | 16 | |
| 12 | 2020 | 16 | |
| 13 | 2012 | 15 | |
| 14 | 2020 | 13 | |
| 15 | 2021 | 12 | |
| 16 | 2023 | 11 | |
| 17 | 2020 | 10 | |
| 18 | 2022 | 9 | |
| 19 | 2023 | 7 | |
| 20 | 2023 | 7 |
About Mabel Catalán
Mabel Catalán is a scholar working on Cardiology and Cardiovascular Medicine, Toxicology, Cancer Research, Molecular Biology and Organic Chemistry, having authored 30 papers that have together received 424 indexed citations. Recurring topics across this work include Cardiac Fibrosis and Remodeling (13 papers), Synthesis and biological activity (5 papers), Mitochondrial Function and Pathology (5 papers), Bioactive Compounds and Antitumor Agents (4 papers), Cardiac Ischemia and Reperfusion (3 papers), Phytochemicals and Antioxidant Activities (2 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Cell death mechanisms and regulation (2 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (108 citations), Toxicology (17 citations), Biochemistry (21 citations), Cancer Research (33 citations) and Molecular Biology (125 citations). Mabel Catalán has collaborated with scholars based in Chile, United States and Spain. Frequent co-authors include Raúl Vivar, Guillermo Dı́az-Araya, Ivonne Olmedo, Jorge Ferreira, Sergio Lavandero, Claudio D Humeres, Pedro Ayala, José Antonio Jara, Lorena Garcı́a and Catalina Carrasco‐Pozo. Their work appears in journals such as Toxicology and Applied Pharmacology, Cellular Signalling, Toxicology in Vitro, Advances in experimental medicine and biology and RSC Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.